NATURE’S SUNSHINE PRODUCTS, INC. Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) reported Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent of 0.00% for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-08.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsQualifiedProductionActivities · last filed 2019-03-08
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2018 was 0.00%.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2017 was 0.00%, a 100.00% decline from fiscal 2016.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2016 was 2.80%, a 115.38% increase from fiscal 2015.
- NATURE’S SUNSHINE PRODUCTS, INC. effective income tax rate reconciliation, deduction, qualified production activity, percent for fiscal 2015 was 1.30%, a 40.91% decline from fiscal 2014.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month | Effective Income Tax Rate Reconciliation, Deduction, Qualified Production Activity, Percent 12 month as first filed |
|---|---|---|
| 2018-12-31 | 0.00% 10-K · filed 2019-03-08 | |
| 2017-12-31 | 0.00% 10-K · filed 2019-03-08 | |
| 2016-12-31 | 2.80% 10-K · filed 2019-03-08 | |
| 2015-12-31 | 1.30% 10-K · filed 2018-03-16 | |
| 2014-12-31 | 2.20% 10-K · filed 2017-03-14 | -2.20% 10-K · filed 2015-03-13 |
| 2013-12-31 | 1.30% 10-K · filed 2016-03-14 | -1.30% 10-K · filed 2014-03-17 |
| 2012-12-31 | -0.40% 10-K · filed 2015-03-13 | |
| 2011-12-31 | -1.10% 10-K · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |